Evaluation of the Nanosphere Verigene BC-GN assay for direct identification of gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions

Journal of Clinical Microbiology

Volumn 52, Issue 10, 2014, Pages 3805-3807

  Hill, Joseph T ^a   Tran, Kim Dung T ^a   Barton, Karen L ^b   Labreche, Matthew J ^b   Sharp, Susan E ^a  

^a Departments of Microbiology   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; CARBAPENEMASE; CEFEPIME; CEFTRIAXONE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT; GENETIC MARKER; NANOSPHERE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CLINICAL DECISION MAKING; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DRUG COST; ENTEROBACTER; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE BLOOD CULTURE ASSAY; GRAM NEGATIVE SEPSIS; GRAM STAINING; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSIS; MORGANELLA MORGANII; NONHUMAN; PASTEURELLA MULTOCIDA; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS STUTZERI; SERRATIA MARCESCENS; TURNAROUND TIME; BLOOD; DRUG EFFECTS; EVALUATION STUDY; GENETIC MARKER; GRAM-NEGATIVE BACTERIAL INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; TIME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; DRUG RESISTANCE, BACTERIAL; GENETIC MARKERS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NANOSPHERES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84907169004     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01537-14     Document Type: Article

References (16)

1. Bearman GM, Wenzel RP. 2005. Bacteremias: a leading cause of death. Arch. Med. Res. 36:646-659. http://dx.doi.org/10.1016/j.arcmed.2005.02 .005.
2. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. 2000. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146-155. http://dx.doi.org/10.1378/chest.118.1.146.
3. Stryjewski M.E., Boucher HW. 2009. Gram-negative bloodstream infections. Int. J. Antimicrob. Agents 34(Suppl 4):S21-S25. http://dx.doi.org/10.1016/S0924-8579(09)70561-8.
4. Nanosphere, Inc. 2014. Verigene Gram-Negative blood culture nucleic acid test (BC-GN) product insert. Revision A. Nanosphere, Inc., Northfield, IL
5. Bauer KA, West JE, Balada-Llasat JM, Pancholi P, Stevenson KB, Goff D.A.. 2010. An antimicrobial stewardship programs impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin. Infect. Dis. 51:1074-1080. http://dx.doi.org/10.1086/656623.
6. Frye AM, Baker CA, Rustvold DL, Heath KA, Hunt J, Leggett JE, Oethinger M. 2012. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J. Clin. Microbiol. 50:127-133. http://dx.doi.org/10.1128/JCM.06169-11.
7. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL, Isip J, Collins CD, Nagel JL. 2013. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin. Infect. Dis. 57:1237-1245. http://dx.doi.org/10.1093/cid/cit498.
8. Kumar A. 2009. Optimizing antimicrobial therapy in sepsis and septic shock. Crit. Care Clin. 25:733-751. http://dx.doi.org/10.1016/j.ccc.2009 .08.004.
9. Sango A, McCarter YS, Johnson D, Ferreira J, Guzman N, Jankowski CA. 2013. Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species. J. Clin. Microbiol. 51:4008-4011. http://dx.doi.org/10.1128/JCM.01951-13.
10. Climo MW, Israel DS, Wong ES, Williams D, Coudron P, Markowitz SM. 1998. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann. Intern. Med. 128:989-995.
11. Wilcox MH, Freeman J, Fawley W, MacKinlay S, Brown A, Donaldson K, Corrado O. 2004. Long-term surveillance of cefoxatime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhea. J. Antimicrob. Chemother. 54:168-172. http://dx.doi.org/10.1093/jac/dkh285.
12. Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. 2007. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin. Infect. Dis. 45:S112-S121. http://dx.doi.org/10.1086/519258.
13. Yeung EYH, Gore JG, Auersperg EV. 2012. A retrospective analysis of the incidence of Clostridium difficile associated diarrhea with meropenem and piperacillin-tazobactam. Int. J. Collabor. Res. Intern. Med. Public Health 4:1567-1576.
14. Mancini N, Infurnari L, Ghidoli N, Valzano G, Clementi N, Burioni R, Clementi M. 2014. Potential impact of a microarray-based nucleic acid assay for rapid detection of Gram-negative bacteria and resistance markers in positive blood cultures. J. Clin. Microbiol. 52:1242-1245. http://dx.doi.org/10.1128/JCM.00142-14.
15. Sullivan KV, Deburger B, Roundtree SS, Ventrola CA, Blecker-Shelly KD, Mortensen JE. 2014. Pediatric multicenter evaluation of the Verigene Gram-negative blood culture test for rapid detection of inpatient bacteremia involving Gram-negative organisms, extended-spectrum betalactamases, and carbapenemases. J. Clin. Microbiol. 52:2416-2421. http://dx.doi.org/10.1128/JCM.00737-14.
16. Tojo M, Fujita T, Ainoda Y, Nagamatsu M, Hayakawa K, Mezaki K, Sakurai A, Masui Y, Yazaki H, Takahashi H, Miyoshi-Akiyama T, Totsuka K, Kirikae T, Ohmagari N. 2014. Evaluation of an automated rapid diagnostic assay for detection of Gram-negative bacteria and their drug-resistance genes in positive blood cultures. PLoS One 9:e94064. http://dx.doi.org/10.1371/journal.pone.0094064.